Traditional fibroblast media utilise 10% serum combined with very simple basal media formulations.<\/p>\n
The new CnT-PR-F<\/a> medium uses an advanced basal medium formulation and a mix of defined growth factors to reduce the serum requirement down to 1%.<\/p>\n As a result, the new CnT-PR-F significantly increases isolation efficiency (50%) and growth rate (+40%)<\/strong>, whilst reducing serum-associated variability.<\/p>\n Cells undergoing rapid proliferation are less responsive to differentiation and ECM-related triggers.<\/p>\n To obtain fully in-vivo like ECM production, we offer the new CnT-PR-ECM<\/a> medium.<\/p>\n CnT-PR-ECM<\/a> is fully defined, and delivers a 5x increase in ECM levels <\/strong>in response to vitamin C treatment compared with the proliferation medium CnT-PR-F.<\/p>\n Caltag Medsystems <\/span><\/a>is the distributor of CellnTech<\/a> products in the UK and Ireland. If you have any questions about these products, please contact<\/span><\/a> us<\/span><\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":" Traditional fibroblast media utilise 10% serum combined with very simple basal media formulations. The new CnT-PR-F medium uses an advanced basal medium formulation and a mix of defined growth factors to reduce the serum requirement down to 1%. As a<\/p>\n","protected":false},"author":13,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[18],"tags":[],"class_list":["post-395","post","type-post","status-publish","format-standard","hentry","category-cell-culture"],"_links":{"self":[{"href":"https:\/\/www.caltagmedsystems.co.uk\/information\/wp-json\/wp\/v2\/posts\/395","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.caltagmedsystems.co.uk\/information\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.caltagmedsystems.co.uk\/information\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.caltagmedsystems.co.uk\/information\/wp-json\/wp\/v2\/users\/13"}],"replies":[{"embeddable":true,"href":"https:\/\/www.caltagmedsystems.co.uk\/information\/wp-json\/wp\/v2\/comments?post=395"}],"version-history":[{"count":4,"href":"https:\/\/www.caltagmedsystems.co.uk\/information\/wp-json\/wp\/v2\/posts\/395\/revisions"}],"predecessor-version":[{"id":7544,"href":"https:\/\/www.caltagmedsystems.co.uk\/information\/wp-json\/wp\/v2\/posts\/395\/revisions\/7544"}],"wp:attachment":[{"href":"https:\/\/www.caltagmedsystems.co.uk\/information\/wp-json\/wp\/v2\/media?parent=395"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.caltagmedsystems.co.uk\/information\/wp-json\/wp\/v2\/categories?post=395"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.caltagmedsystems.co.uk\/information\/wp-json\/wp\/v2\/tags?post=395"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}